Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 10-2024 | 07-2024 | 04-2024 | 01-2024 | 10-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,142 | -39,843 | -25,695 | -10,711 | -99,917 |
| Depreciation Amortization | 91 | 240 | 158 | 80 | 175 |
| Accounts payable and accrued liabilities | 474 | 1,919 | -689 | 217 | 373 |
| Other Working Capital | 95 | 6,128 | 984 | 2,347 | -517 |
| Other Operating Activity | 6,201 | 2,843 | 3,710 | 697 | 75,143 |
| Operating Cash Flow | $-48,281 | $-28,713 | $-21,532 | $-7,370 | $-24,743 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -125,028 | N/A | N/A | N/A | N/A |
| PPE Investments | -925 | -687 | -685 | -506 | -318 |
| Investing Cash Flow | $-125,953 | $-687 | $-685 | $-506 | $-318 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 38,000 |
| Debt Issued | 22,500 | 22,500 | 22,500 | 22,500 | N/A |
| Debt Repayment | -9,445 | -9,445 | -9,445 | -9,445 | -1,555 |
| Common Stock Issued | 266,245 | 206,085 | 206,034 | N/A | 56,936 |
| Other Financing Activity | -13,584 | -13,584 | -13,584 | -1,055 | -7,234 |
| Financing Cash Flow | $265,716 | $205,556 | $205,505 | $12,000 | $86,147 |
| Exchange Rate Effect | 1 | 1 | 1 | 1 | 1 |
| Beginning Cash Position | 81,521 | 81,521 | 81,521 | 81,521 | 20,434 |
| End Cash Position | 173,004 | 257,678 | 264,810 | 85,646 | 81,521 |
| Net Cash Flow | $91,483 | $176,157 | $183,289 | $4,125 | $61,087 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,281 | -28,713 | -21,532 | -7,370 | -24,743 |
| Capital Expenditure | -925 | -687 | -685 | -506 | -318 |
| Free Cash Flow | -49,206 | -29,400 | -22,217 | -7,876 | -25,061 |